# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-283275
Filing Date
2025-11-14
Accepted
2025-11-14 17:05:47
Documents
74
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | eldn-20250930.htm iXBRL | 10-Q | 3312223
2 | EX-31.1 | eldn-ex31_1.htm | EX-31.1 | 16732
3 | EX-31.2 | eldn-ex31_2.htm | EX-31.2 | 17008
4 | EX-32.1 | eldn-ex32_1.htm | EX-32.1 | 11266
5 | EX-32.2 | eldn-ex32_2.htm | EX-32.2 | 11331
| Complete submission text file | 0001193125-25-283275.txt |  | 12648794

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | eldn-20250930.xsd | EX-101.SCH | 1356489
77 | EXTRACTED XBRL INSTANCE DOCUMENT | eldn-20250930_htm.xml | XML | 2687670

Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36620 | Film No.: 251488034
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)